1 hr. ago
What type of jet is missing off Nantucket?
Where was the missing jet traveling from and to?
What was the outcome of Christa Pike's botched execution?
Full Summary
The U.S. Coast Guard is searching off the coast of Nantucket for a missing jet carrying six people after it went missing the morning of Oct. 3.
#full #guard #type #outcome
Where was the missing jet traveling from and to?
What was the outcome of Christa Pike's botched execution?
Full Summary
The U.S. Coast Guard is searching off the coast of Nantucket for a missing jet carrying six people after it went missing the morning of Oct. 3.
#full #guard #type #outcome
4 days ago
By Andrew Chung
Sept 29 (Reuters) - The US Supreme Court on Tuesday let President Donald Trump's administration resume deporting migrants to countries other than their own without offering them the chance to show the harms they may face, bolstering a tool his administration has used for rapid expulsions as part of his immigration crackdown.
The court granted the Justice Department's emergency request to put on hold Boston-based US District Judge Brian Murphy's ruling that the Department of Homeland Security's policy to remove migrants to so-called third countries is unlawful. The court also agreed to hear arguments in the dispute in December, with a formal ruling on the policy to follow.
The court has a 6-3 conservative majority. Its three liberal justices dissented from the decision to let the deportations immediately resume pending the final outcome of the litigation.
Murphy's ruling came in a class-action lawsuit filed by immigrant rights groups on behalf of migrants seeking to prevent the US government from sending them to third countries without notice and a chance to **** ert the harms they could face.
#migrants #chance #harms
Sept 29 (Reuters) - The US Supreme Court on Tuesday let President Donald Trump's administration resume deporting migrants to countries other than their own without offering them the chance to show the harms they may face, bolstering a tool his administration has used for rapid expulsions as part of his immigration crackdown.
The court granted the Justice Department's emergency request to put on hold Boston-based US District Judge Brian Murphy's ruling that the Department of Homeland Security's policy to remove migrants to so-called third countries is unlawful. The court also agreed to hear arguments in the dispute in December, with a formal ruling on the policy to follow.
The court has a 6-3 conservative majority. Its three liberal justices dissented from the decision to let the deportations immediately resume pending the final outcome of the litigation.
Murphy's ruling came in a class-action lawsuit filed by immigrant rights groups on behalf of migrants seeking to prevent the US government from sending them to third countries without notice and a chance to **** ert the harms they could face.
#migrants #chance #harms
13 days ago
On Sept. 15, 2016, Shopify (NASDAQ:SHOP) stock closed at a split-adjusted $4.18 per share. As of this writing, shares trade around $130. That comes out to about 31 times the initial investment -- enough to make a $10,000 stake bought that day worth about $311,000 today.
And because Shopify does not pay a dividend, the share price did all the work.
Missed AI's "Act 1"? Act 2 Could Be 15x Bigger. Most investors think they missed the AI boat because they didn't buy Nvidia in 2005. But according to our **** ysts, we're only at the end of "Act 1"—the R&D phase. "Act 2" is the global rollout. Continue »
For comparison, the S&P 500 (SNPINDEX:^GSPC) had an outstanding decade of its own. The same $10,000 in an index fund that tracks the benchmark, with dividends reinvested, would have become about $41,000 during that period.
Most investors would be delighted with that outcome. Shopify's was more than seven times better.
#sept
And because Shopify does not pay a dividend, the share price did all the work.
Missed AI's "Act 1"? Act 2 Could Be 15x Bigger. Most investors think they missed the AI boat because they didn't buy Nvidia in 2005. But according to our **** ysts, we're only at the end of "Act 1"—the R&D phase. "Act 2" is the global rollout. Continue »
For comparison, the S&P 500 (SNPINDEX:^GSPC) had an outstanding decade of its own. The same $10,000 in an index fund that tracks the benchmark, with dividends reinvested, would have become about $41,000 during that period.
Most investors would be delighted with that outcome. Shopify's was more than seven times better.
#sept
13 days ago
September 18, 2026 / 8:03 PM EDT / CBS News
During his ex-wife's murder trial, Patrick Clancy faced intense scrutiny online, with social media users often questioning his character. Now, as he reflects on the tragedy, Clancy says he believes he did the best he could with the information he had at the time.
"I think I did the best I could with what I had at the time, and I live with the outcome. I live with it every day, but I think I did the best I could," Clancy told correspondent Ross Douthat after being asked whether he feels angry with himself or like he failed in some way.
He and his wife, Dr. Rachel Danis, spoke with 60 Minutes after Lindsay Clancy's case ended in a mistrial.
Lindsay Clancy's defense team has argued that she was suffering from postpartum psychosis when she killed their three children, 5-year-old Cora, 3-year-old Dawson, and 8-month-old Callan in January 2023.
#best #year #patrick
During his ex-wife's murder trial, Patrick Clancy faced intense scrutiny online, with social media users often questioning his character. Now, as he reflects on the tragedy, Clancy says he believes he did the best he could with the information he had at the time.
"I think I did the best I could with what I had at the time, and I live with the outcome. I live with it every day, but I think I did the best I could," Clancy told correspondent Ross Douthat after being asked whether he feels angry with himself or like he failed in some way.
He and his wife, Dr. Rachel Danis, spoke with 60 Minutes after Lindsay Clancy's case ended in a mistrial.
Lindsay Clancy's defense team has argued that she was suffering from postpartum psychosis when she killed their three children, 5-year-old Cora, 3-year-old Dawson, and 8-month-old Callan in January 2023.
#best #year #patrick
13 days ago
Tegan Lecheler, founder and director of Mothers & Infant Cash Coalition, told Fox News Digital its support for cash ****** istance has been praised by the right.
Although guaranteed income programs have faced partisan pushback nationwide since gaining national traction in 2018, a growing faction of conservatives is finding common ground with direct cash initiatives centered on mothers and newborns.
According to Tegan Lecheler, national program director for the Mother and Infant Cash Coalition (MICC), the "common-sense" nature of early childhood cash transfers has prompted conservative lawmakers and advocates to reach out to her organization in support.
"I think we're in a really polarized time politically right now," Lecheler told Fox News Digital. "We are not a political organization and want to work to improve families' outcomes. We believe an effective strategy for doing that is to build a big tent – a wide tent with a lot of people underneath it."
EXCLUSIVE: PENCE GROUP KNOCKS VANCE PLAN TO PAY STAY-AT-HOME PARENTS UP TO $9K PER CHILD
#support
Although guaranteed income programs have faced partisan pushback nationwide since gaining national traction in 2018, a growing faction of conservatives is finding common ground with direct cash initiatives centered on mothers and newborns.
According to Tegan Lecheler, national program director for the Mother and Infant Cash Coalition (MICC), the "common-sense" nature of early childhood cash transfers has prompted conservative lawmakers and advocates to reach out to her organization in support.
"I think we're in a really polarized time politically right now," Lecheler told Fox News Digital. "We are not a political organization and want to work to improve families' outcomes. We believe an effective strategy for doing that is to build a big tent – a wide tent with a lot of people underneath it."
EXCLUSIVE: PENCE GROUP KNOCKS VANCE PLAN TO PAY STAY-AT-HOME PARENTS UP TO $9K PER CHILD
#support
14 days ago
Concerned about an AI bubble? Sign up for The Daily Upside for smart and actionable market news, built for investors.
There's a lot we can't predict, like the outcome of the midterm elections, who will make it to the Super Bowl or whether Taylor Swift was actually hinting at a new album release in that Emmy's sketch. But when it comes to what our retirement looks like, we can certainly try.
Many retirement plans offer predictive tools that can help savers forecast their future balances, retirement readiness, income replacement rates and more. Participants, however, aren't happy with the options: J.D. Power's recent survey of digital experience satisfaction for retirement plans found that predictive tools were the lowest-performing attribute.
"The technology in the 401(k) is seriously behind what people are used to in their consumer life," said Fred Barstein, CEO of The Retirement Advisor University. When the underlying technology structure is old and **** bersome, it's hard for the tools to be as effective as they could be.
Sign up for The Daily Upside at no cost for premium **** ysis on all your favorite stocks.
#tools #sign #upside #like
There's a lot we can't predict, like the outcome of the midterm elections, who will make it to the Super Bowl or whether Taylor Swift was actually hinting at a new album release in that Emmy's sketch. But when it comes to what our retirement looks like, we can certainly try.
Many retirement plans offer predictive tools that can help savers forecast their future balances, retirement readiness, income replacement rates and more. Participants, however, aren't happy with the options: J.D. Power's recent survey of digital experience satisfaction for retirement plans found that predictive tools were the lowest-performing attribute.
"The technology in the 401(k) is seriously behind what people are used to in their consumer life," said Fred Barstein, CEO of The Retirement Advisor University. When the underlying technology structure is old and **** bersome, it's hard for the tools to be as effective as they could be.
Sign up for The Daily Upside at no cost for premium **** ysis on all your favorite stocks.
#tools #sign #upside #like
14 days ago
On September 16, Evolution Petroleum Corporation (NYSEAMERICAN:EPM) held its fiscal fourth-quarter and full-year 2026 earnings call, and the numbers told a story of a company climbing out of a rough patch. Revenue jumped 20% sequentially to $24.2 million as oil prices realized before hedge settlements shot up 49% year over year to $90.74 a barrel. Adjusted EBITDA more than doubled to $6.5 million. After a bruising third quarter, the fourth quarter finally looked like the recovery management had promised investors back in May.
The fourth-quarter turnaround wasn't just about crude. NGL prices realized $32.49 a barrel, up 27% year over year, and because Evolution leaves its NGL production entirely unhedged, every dollar of that gain flowed straight through. That combination of higher liquids pricing, growing production, and the roll-off of a prior-period transportation adjustment at the Delhi Field pushed operating cash flow to $6.8 million in the quarter, nearly double the $3.5 million generated in the third quarter.
Behind the quarterly numbers sits a longer-term shift in how Evolution makes money. The company closed a roughly $16 million acquisition of mineral and royalty acreage in the Permian's Midland Basin after the fiscal year ended, adding about 3,420 net royalty acres and more than 200 barrels of oil equivalent per day of current production, all without Evolution spending a dime on development. That mirrors what's already happening in the SCOOP/STACK play, where fourth-quarter production climbed 14% year over year to 1,275 BOE per day while unit operating costs fell to $10.33 a barrel. Evolution also replaced more than 100% of the 2.6 million barrels of oil equivalent it produced during the year, ending fiscal 2026 with 27.2 million barrels of proved reserves, an outcome that matters directly to a dividend now in its 52nd consecutive quarter.
Not every part of the business bounced back. Average daily production fell 4% year over year to 6,901 barrels of oil equivalent per day, largely because the flush production from new Chaveroo wells that boosted last year's fourth quarter has since tapered off. Natural gas pricing remained the softest spot in the portfolio, especially at the Jonah Field, where CEO Kelly Loyd said "regional differentials have weighed on realizations" even as broader demand for gas keeps growing. CFO Ryan Stash noted that stronger oil and NGL results helped offset "continued weakness in natural gas realizations, particularly at Jonah."
#barrel
The fourth-quarter turnaround wasn't just about crude. NGL prices realized $32.49 a barrel, up 27% year over year, and because Evolution leaves its NGL production entirely unhedged, every dollar of that gain flowed straight through. That combination of higher liquids pricing, growing production, and the roll-off of a prior-period transportation adjustment at the Delhi Field pushed operating cash flow to $6.8 million in the quarter, nearly double the $3.5 million generated in the third quarter.
Behind the quarterly numbers sits a longer-term shift in how Evolution makes money. The company closed a roughly $16 million acquisition of mineral and royalty acreage in the Permian's Midland Basin after the fiscal year ended, adding about 3,420 net royalty acres and more than 200 barrels of oil equivalent per day of current production, all without Evolution spending a dime on development. That mirrors what's already happening in the SCOOP/STACK play, where fourth-quarter production climbed 14% year over year to 1,275 BOE per day while unit operating costs fell to $10.33 a barrel. Evolution also replaced more than 100% of the 2.6 million barrels of oil equivalent it produced during the year, ending fiscal 2026 with 27.2 million barrels of proved reserves, an outcome that matters directly to a dividend now in its 52nd consecutive quarter.
Not every part of the business bounced back. Average daily production fell 4% year over year to 6,901 barrels of oil equivalent per day, largely because the flush production from new Chaveroo wells that boosted last year's fourth quarter has since tapered off. Natural gas pricing remained the softest spot in the portfolio, especially at the Jonah Field, where CEO Kelly Loyd said "regional differentials have weighed on realizations" even as broader demand for gas keeps growing. CFO Ryan Stash noted that stronger oil and NGL results helped offset "continued weakness in natural gas realizations, particularly at Jonah."
#barrel
14 days ago
On September 8, 2026, CNBC reported that Novartis' failed pelacarsen trial has raised the stakes for rival experimental cholesterol drugs from Amgen Inc. (NASDAQ:AMGN) and Eli Lilly and Company (NYSE:LLY), both of which are racing to prove that lowering lipoprotein(a), or Lp(a). It can meaningfully reduce heart attacks and strokes.
Analysts said Amgen's olpasiran faces the clearest negative read-through given its similar trial design. Lilly's lepodisiran is being tested in a broader patient population that could limit how directly Novartis' failure applies. It is also described as less material to Lilly's overall valuation than pelacarsen was for Novartis.
Copyright: stocking / 123RF Stock Photo
Amgen Inc. (NASDAQ:AMGN) and Eli Lilly and Company (NYSE:LLY) could still succeed where Novartis failed. Pelacarsen's failure does not establish that lowering Lp(a) cannot reduce cardiovascular events. **** ysts noted that Novartis' trial faced a high statistical hurdle and that Amgen's olpasiran and Lilly's lepodisiran have produced stronger Lp(a) reductions in earlier studies. Both companies also continue testing their drugs in specific patient populations with high Lp(a). It leaves room for their trials to produce different outcomes from Novartis' study.
Lilly's lepodisiran faces a less direct read-through than Amgen's olpasiran. **** ysts view Amgen's olpasiran as the closest comparison to pelacarsen because the programs use similar trial designs. Lilly's lepodisiran is being tested in an overall patient population. It could make Novartis' failure less directly applicable. **** ysts also view lepodisiran as less material to Lilly's overall valuation than pelacarsen was to Novartis. It reduces the potential financial impact of an unsuccessful outcome.
#lepodisiran #less
Analysts said Amgen's olpasiran faces the clearest negative read-through given its similar trial design. Lilly's lepodisiran is being tested in a broader patient population that could limit how directly Novartis' failure applies. It is also described as less material to Lilly's overall valuation than pelacarsen was for Novartis.
Copyright: stocking / 123RF Stock Photo
Amgen Inc. (NASDAQ:AMGN) and Eli Lilly and Company (NYSE:LLY) could still succeed where Novartis failed. Pelacarsen's failure does not establish that lowering Lp(a) cannot reduce cardiovascular events. **** ysts noted that Novartis' trial faced a high statistical hurdle and that Amgen's olpasiran and Lilly's lepodisiran have produced stronger Lp(a) reductions in earlier studies. Both companies also continue testing their drugs in specific patient populations with high Lp(a). It leaves room for their trials to produce different outcomes from Novartis' study.
Lilly's lepodisiran faces a less direct read-through than Amgen's olpasiran. **** ysts view Amgen's olpasiran as the closest comparison to pelacarsen because the programs use similar trial designs. Lilly's lepodisiran is being tested in an overall patient population. It could make Novartis' failure less directly applicable. **** ysts also view lepodisiran as less material to Lilly's overall valuation than pelacarsen was to Novartis. It reduces the potential financial impact of an unsuccessful outcome.
#lepodisiran #less
14 days ago
On September 7, 2026, Reuters reported that Novo Nordisk A/S (NYSE:NVO) halted two additional trials of its experimental cardiovascular drug ziltivekimab, further denting the Danish drugmaker's efforts to diversify beyond its blockbuster obesity and diabetes franchise.
The move follows a July disclosure that ziltivekimab failed to reduce major adverse cardiovascular events in a late-stage trial. An independent data monitoring committee found a "low likelihood" that the two additional heart-failure studies would produce a different result from that earlier failure, prompting Novo to end them ahead of schedule.
Novo Nordisk A/S (NYSE:NVO) still has one opportunity to create value from its cardiovascular program. The company will continue testing ziltivekimab in patients recovering from a heart attack, with results expected in the first half of 2027. A successful outcome could give Novo another growth opportunity outside its obesity and diabetes franchise.
Novo's core obesity and diabetes business remains the much larger driver of its financial performance. The oral Wegovy pill has already generated more than 2 million prescriptions shortly after its January 2026 launch. It gives Novo an important growth opportunity as the company competes with Eli Lilly in the oral GLP-1 market.
The company can also preserve capital by ending trials that show limited prospects for success. An independent data monitoring committee found a low likelihood that the two heart-failure studies would produce different results from the earlier failed trial. Novo can redirect the resources it would have spent on those studies toward higher-potential programs.
#obesity #diabetes
The move follows a July disclosure that ziltivekimab failed to reduce major adverse cardiovascular events in a late-stage trial. An independent data monitoring committee found a "low likelihood" that the two additional heart-failure studies would produce a different result from that earlier failure, prompting Novo to end them ahead of schedule.
Novo Nordisk A/S (NYSE:NVO) still has one opportunity to create value from its cardiovascular program. The company will continue testing ziltivekimab in patients recovering from a heart attack, with results expected in the first half of 2027. A successful outcome could give Novo another growth opportunity outside its obesity and diabetes franchise.
Novo's core obesity and diabetes business remains the much larger driver of its financial performance. The oral Wegovy pill has already generated more than 2 million prescriptions shortly after its January 2026 launch. It gives Novo an important growth opportunity as the company competes with Eli Lilly in the oral GLP-1 market.
The company can also preserve capital by ending trials that show limited prospects for success. An independent data monitoring committee found a low likelihood that the two heart-failure studies would produce different results from the earlier failed trial. Novo can redirect the resources it would have spent on those studies toward higher-potential programs.
#obesity #diabetes
15 days ago
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) reported on September 14 that fiscal first-quarter 2027 revenue increased 60% to $31.0 million. Gross margin reached 56.5%, up from 45.7%, for the quarter ended July 31, 2026.
Management raised fiscal 2027 revenue guidance to $141 million from $137 million, implying 48% annual growth. The outlook strengthens the commercial story, but the expanding organization still consumes substantially more than the business generates in gross profit.
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) attributed revenue growth to wearable cardioverter defibrillator market expansion, competitive share gains, new sales territories, a higher proportion of in-network patients and improvements in revenue cycle management.
These drivers suggest several ways to expand: reach more patients, improve reimbursement outcomes, and collect revenue more effectively. Their investment value depends on sustaining growth without requiring a matching increase in support costs.
Gross profit nearly doubled to $17.5 million from $8.9 million. Management attributed the margin improvement to higher volume, the in-network patient mix, and cost initiatives. The company is retaining more of each revenue dollar to fund selling expenses and product development.
#million #kestra #kmts
Management raised fiscal 2027 revenue guidance to $141 million from $137 million, implying 48% annual growth. The outlook strengthens the commercial story, but the expanding organization still consumes substantially more than the business generates in gross profit.
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) attributed revenue growth to wearable cardioverter defibrillator market expansion, competitive share gains, new sales territories, a higher proportion of in-network patients and improvements in revenue cycle management.
These drivers suggest several ways to expand: reach more patients, improve reimbursement outcomes, and collect revenue more effectively. Their investment value depends on sustaining growth without requiring a matching increase in support costs.
Gross profit nearly doubled to $17.5 million from $8.9 million. Management attributed the margin improvement to higher volume, the in-network patient mix, and cost initiatives. The company is retaining more of each revenue dollar to fund selling expenses and product development.
#million #kestra #kmts
15 days ago
Ascendis Pharma A/S (NASDAQ:ASND) announced on September 14 that it will regain exclusive rights to develop, manufacture, and commercialize TransCon products in metabolic and cardiovascular diseases following the termination of its collaboration with Novo Nordisk A/S (NYSE:NVO).
The rights include once-monthly TransCon Semaglutide, an investigational long-acting prodrug of semaglutide intended for obesity and type 2 diabetes. Neither party will have continuing financial obligations to the other. Once termination becomes effective and the rights revert, management plans to initiate multiple programs across rare and large indications.
The investment question is whether greater control over future products can justify the resources needed to develop them.
Ascendis Pharma A/S (NASDAQ:ASND) would regain flexibility over which indications to pursue, how quickly to advance candidates, and whether to seek another partner. Successful independent development could retain more of a product's commercial economics, while a new collaboration could provide another way to share costs and risk.
Monthly dosing offers a clear development objective. If clinical studies demonstrate effective treatment with acceptable tolerability, fewer injections could make long-term therapy more convenient. That potential benefit would matter most if it helps patients stay on treatment without sacrificing outcomes.
#ascendis #pharma #asnd #regain
The rights include once-monthly TransCon Semaglutide, an investigational long-acting prodrug of semaglutide intended for obesity and type 2 diabetes. Neither party will have continuing financial obligations to the other. Once termination becomes effective and the rights revert, management plans to initiate multiple programs across rare and large indications.
The investment question is whether greater control over future products can justify the resources needed to develop them.
Ascendis Pharma A/S (NASDAQ:ASND) would regain flexibility over which indications to pursue, how quickly to advance candidates, and whether to seek another partner. Successful independent development could retain more of a product's commercial economics, while a new collaboration could provide another way to share costs and risk.
Monthly dosing offers a clear development objective. If clinical studies demonstrate effective treatment with acceptable tolerability, fewer injections could make long-term therapy more convenient. That potential benefit would matter most if it helps patients stay on treatment without sacrificing outcomes.
#ascendis #pharma #asnd #regain
15 days ago
Investors continue to ask for more timely information, even as the volume available to them expands. A 2026 CFA Institute survey of 2,500 **** ysts and portfolio managers found that 62% opposed replacing quarterly reporting with semiannual reporting. Nearly 85% expressed concern about comparability if companies and investment managers could determine their own reporting frequency and format. Access remains important, while interpretation requires a separate discipline.
The demand also concerns the quality of disclosure. PwC's 2025 Global Investor Survey, covering 1,074 investment professionals across 26 countries and territories, found that only 37% believed companies disclosed enough about artificial intelligence strategies and policies. Respondents wanted greater transparency around innovation strategies, AI investment, and expected returns. These findings suggest that investors can face abundant commentary while still lacking the evidence needed to **** s a thesis.
Commercial incentives add another layer. A 2025 CFA Institute report examined continuation funds, in which a manager can oversee both the vehicle selling an **** et and the vehicle buying it. The report recognized the structure's liquidity role and identified conflicts requiring fair processes and governance. The example illustrates why informed **** ysis and aligned incentives are separate considerations.
That distinction applies beyond any single investment structure. Managers often possess valuable operational knowledge because they work directly with **** ets, tenants and financing markets. They may also be raising capital for the strategies they discuss. Their commercial interest becomes additional context for investors weighing forecasts, market narratives and recommendations alongside independently produced evidence. That context can help an investment committee separate a source's knowledge of the market from the confidence it should place in the source's preferred outcome during capital allocation.
Geoffrey Dohrmann, chairman, CEO and editor-in-chief of Institutional Real Estate, Inc., has watched those narratives develop across several market cycles. IREI is a media and market intelligence company covering institutional real estate and infrastructure through publications, research, data, events and consulting. Dohrmann explains its editorial role as independently recording where real-asset capital is moving and examining the explanations offered for those decisions.
#real #institute
The demand also concerns the quality of disclosure. PwC's 2025 Global Investor Survey, covering 1,074 investment professionals across 26 countries and territories, found that only 37% believed companies disclosed enough about artificial intelligence strategies and policies. Respondents wanted greater transparency around innovation strategies, AI investment, and expected returns. These findings suggest that investors can face abundant commentary while still lacking the evidence needed to **** s a thesis.
Commercial incentives add another layer. A 2025 CFA Institute report examined continuation funds, in which a manager can oversee both the vehicle selling an **** et and the vehicle buying it. The report recognized the structure's liquidity role and identified conflicts requiring fair processes and governance. The example illustrates why informed **** ysis and aligned incentives are separate considerations.
That distinction applies beyond any single investment structure. Managers often possess valuable operational knowledge because they work directly with **** ets, tenants and financing markets. They may also be raising capital for the strategies they discuss. Their commercial interest becomes additional context for investors weighing forecasts, market narratives and recommendations alongside independently produced evidence. That context can help an investment committee separate a source's knowledge of the market from the confidence it should place in the source's preferred outcome during capital allocation.
Geoffrey Dohrmann, chairman, CEO and editor-in-chief of Institutional Real Estate, Inc., has watched those narratives develop across several market cycles. IREI is a media and market intelligence company covering institutional real estate and infrastructure through publications, research, data, events and consulting. Dohrmann explains its editorial role as independently recording where real-asset capital is moving and examining the explanations offered for those decisions.
#real #institute
16 days ago
Cipher Digital (NASDAQ: CIFR) stock is roaring higher on Wednesday. The company's share price was up 13.9% as of 10:35 a.m. ET. At the same point in the daily session, the S&P 500 and the Nasdaq Composite were up 0.2% and 0.6%, respectively.
After recent sell-offs driven by concerns about the potential for increased regulation in the artificial intelligence (AI) industry, stocks in the category are seeing some rebound trading in today's session. In addition to that bullish catalyst, Cipher Digital stock is getting a big boost from news connected to its Texas data center projects.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
The potential for AI to create dangerous outcomes has been a center-stage news item and point of political discussion recently, and increased focus on the topic has powered some valuation pullbacks for artificial intelligence companies. Calls for increased regulation of the AI industry have caused concerns among investors that growth in the category could be impeded, but stocks in the ******* e are broadly seeing some rebound momentum in today's trading.
Before the market opened this morning, the Electric Reliability Council of Texas (ERCOT) published an update through its Batch Zero evaluation framework indicating grid capacity of up to 3.2 gigawatts for Cipher's data centers in the state. The update bodes well for the scaling of the company's AI compute business, and investors are bidding up the stock today in response.
#Stock #cipher #same
After recent sell-offs driven by concerns about the potential for increased regulation in the artificial intelligence (AI) industry, stocks in the category are seeing some rebound trading in today's session. In addition to that bullish catalyst, Cipher Digital stock is getting a big boost from news connected to its Texas data center projects.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
The potential for AI to create dangerous outcomes has been a center-stage news item and point of political discussion recently, and increased focus on the topic has powered some valuation pullbacks for artificial intelligence companies. Calls for increased regulation of the AI industry have caused concerns among investors that growth in the category could be impeded, but stocks in the ******* e are broadly seeing some rebound momentum in today's trading.
Before the market opened this morning, the Electric Reliability Council of Texas (ERCOT) published an update through its Batch Zero evaluation framework indicating grid capacity of up to 3.2 gigawatts for Cipher's data centers in the state. The update bodes well for the scaling of the company's AI compute business, and investors are bidding up the stock today in response.
#Stock #cipher #same
16 days ago
An **** ysis of recent filings from American politicians shows that Accenture (NYSE: ACN) and Boston Scientific (NYSE: BSX) saw an uptick in purchases from notable politicians. Rep. Gilbert Ray Cisneros, Jr. (D-CA) bought Boston Scientific shares, according to a filing earlier this month. The trade was made on August 18, 2026. Rep. Ro Khanna (D-CA) also bought the stock twice, on August 3 and August 10, 2026, according to a filing filed on September 4, 2026. Neither politician sold Boston Scientific shares in the same period. Cisneros and Khanna were also the two buyers of Accenture shares in July and August.
This is based on data from Quiver Quantitative, a platform that tracks congressional stock trades from politicians.
Let's focus on BSX in this article.
BSX is down about 50% so far this year amid a cyberattack that disrupted manufacturing, order processing and shipments, forcing the company to withdraw its previous third-quarter and full-year outlook. Bulls say the market has priced in too severe an outcome. By Sept. 8, the company said its major distribution centers were shipping at or above normal levels, sterilization facilities were operating, and manufacturing had restarted at most plants. Bulls believe much of the disrupted revenue could be delayed rather than permanently lost as hospitals wait for products, reschedule procedures and the company works through its backlog.
Bulls also point to a business that was still growing. Second-quarter revenue rose 7.5% year over year and organic growth was 7%. Several core franchises delivered double-digit organic growth, including Interventional Cardiology and Vascular Therapies, Interventional Oncology and Embolization, and Neuromodulation.
#august #NYSE
This is based on data from Quiver Quantitative, a platform that tracks congressional stock trades from politicians.
Let's focus on BSX in this article.
BSX is down about 50% so far this year amid a cyberattack that disrupted manufacturing, order processing and shipments, forcing the company to withdraw its previous third-quarter and full-year outlook. Bulls say the market has priced in too severe an outcome. By Sept. 8, the company said its major distribution centers were shipping at or above normal levels, sterilization facilities were operating, and manufacturing had restarted at most plants. Bulls believe much of the disrupted revenue could be delayed rather than permanently lost as hospitals wait for products, reschedule procedures and the company works through its backlog.
Bulls also point to a business that was still growing. Second-quarter revenue rose 7.5% year over year and organic growth was 7%. Several core franchises delivered double-digit organic growth, including Interventional Cardiology and Vascular Therapies, Interventional Oncology and Embolization, and Neuromodulation.
#august #NYSE
16 days ago
If online prediction markets are correct, the Democrats are likely to win back the House and Senate in November. On Polymarket, there's currently a 53% chance of a Democratic sweep.
If you're a crypto investor, that outcome could have important consequences for your portfolio. That's especially the case if Democrats delay, roll back, or block important pro-crypto legislation. With that in mind, here's one crypto to buy and one crypto to sell.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
My one crypto to buy is Bitcoin (CRYPTO: BTC). It is still the most popular cryptocurrency, accounting for a whopping 60% of the crypto market's total $2.6 trillion market cap. As Bitcoin goes, so goes the crypto market.
As a result, Bitcoin currently has the support of both Wall Street and the White House, so any political fallout from the midterm elections in the event of a Democratic sweep should be minimal. Regulators already agree that Bitcoin is a commodity, not a security. Thus, even if the Clarity Act does not pass this year, it shouldn't have a direct impact on the regulatory status of Bitcoin and how institutional investors view it.
#NVIDIA #flashing #total
If you're a crypto investor, that outcome could have important consequences for your portfolio. That's especially the case if Democrats delay, roll back, or block important pro-crypto legislation. With that in mind, here's one crypto to buy and one crypto to sell.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
My one crypto to buy is Bitcoin (CRYPTO: BTC). It is still the most popular cryptocurrency, accounting for a whopping 60% of the crypto market's total $2.6 trillion market cap. As Bitcoin goes, so goes the crypto market.
As a result, Bitcoin currently has the support of both Wall Street and the White House, so any political fallout from the midterm elections in the event of a Democratic sweep should be minimal. Regulators already agree that Bitcoin is a commodity, not a security. Thus, even if the Clarity Act does not pass this year, it shouldn't have a direct impact on the regulatory status of Bitcoin and how institutional investors view it.
#NVIDIA #flashing #total
16 days ago
As markets anxiously await the outcome of the current FOMC meeting, Treasury yields notched new 19-year highs in trading Tuesday. The closely watched 10-year surpassed 5.0% Tuesday morning in a high not seen since July 2007. Even the 30-year Treasury yield rose sharply, hitting 5.4%, its highest since June 2007.
In addition to worries over persistent, rising core inflation (one of the Fed's preferred inflation measurements), skyrocketing oil prices and shortages create further pressure on Treasuries. Currently, the rolling one-month correlation between the 10-year Treasury yield and front-month WTI (West Texas Intermediate) crude sits at 0.96 per BMO Capital Markets ****** ysis.
Bond yields and oil prices have moved in tandem for much of this year as investors position for the longer-term inflationary impact of higher oil prices. And with major oil execs sounding the alarm on global supply cache shortages and strategic reserves depletion that help to temporarily soften spiking oil prices for consumers, these pricing pressures are likely to continue in the near-term. Saudi Arabia announced the closure of its East-West pipeline that bypassed the Strait of Hormuz after it came under attack late last week, and cancelled some shipments to Europe, reported Reuters.
"Normally, the relationship isn't as clean as it is now, but the geopolitical drivers behind the price of oil and global inflation are so prominent that the normally modest correlation has become much tighter," Steve Sosnick, Chief Strategist, Interactive Brokers told CNBC. "As long as oil prices remain firm and continue to drift higher, this will add pressure to interest rates."
As macro uncertainty continues and inflation persists, bonds and oil/energy will be categories to keep a weather eye towards and could see renewed ETF investor attention. Currently, investors are seizing the opportunity in longer-term bonds, with $9.7 billion flowing into the iShares 20+ Year Treasury Bond ETF (TLT) in the last three months though the fund is only up $3.4 billion net YTD according to FactSet data. It will be a category likely to see action in the wake of the FOMC rate decision. As bond yields climb, prices fall as they move inverse to each other, and should yields climb higher, investors may choose to scoop up longer duration bonds at depreciated prices for future gains. However, an exodus is more likely until the path of rate hikes becomes more certain.
#treasury #longer #higher
In addition to worries over persistent, rising core inflation (one of the Fed's preferred inflation measurements), skyrocketing oil prices and shortages create further pressure on Treasuries. Currently, the rolling one-month correlation between the 10-year Treasury yield and front-month WTI (West Texas Intermediate) crude sits at 0.96 per BMO Capital Markets ****** ysis.
Bond yields and oil prices have moved in tandem for much of this year as investors position for the longer-term inflationary impact of higher oil prices. And with major oil execs sounding the alarm on global supply cache shortages and strategic reserves depletion that help to temporarily soften spiking oil prices for consumers, these pricing pressures are likely to continue in the near-term. Saudi Arabia announced the closure of its East-West pipeline that bypassed the Strait of Hormuz after it came under attack late last week, and cancelled some shipments to Europe, reported Reuters.
"Normally, the relationship isn't as clean as it is now, but the geopolitical drivers behind the price of oil and global inflation are so prominent that the normally modest correlation has become much tighter," Steve Sosnick, Chief Strategist, Interactive Brokers told CNBC. "As long as oil prices remain firm and continue to drift higher, this will add pressure to interest rates."
As macro uncertainty continues and inflation persists, bonds and oil/energy will be categories to keep a weather eye towards and could see renewed ETF investor attention. Currently, investors are seizing the opportunity in longer-term bonds, with $9.7 billion flowing into the iShares 20+ Year Treasury Bond ETF (TLT) in the last three months though the fund is only up $3.4 billion net YTD according to FactSet data. It will be a category likely to see action in the wake of the FOMC rate decision. As bond yields climb, prices fall as they move inverse to each other, and should yields climb higher, investors may choose to scoop up longer duration bonds at depreciated prices for future gains. However, an exodus is more likely until the path of rate hikes becomes more certain.
#treasury #longer #higher
16 days ago
Steel and materials markets fluctuated between rallies and pullbacks as the US-Canada trade relationship shifted from near agreement to open dispute. Nucor Corporation (NYSE:NUE) and Cleveland-Cliffs Inc. (NYSE:CLF) rose on August 25, after discussions between the two countries broke down, a turnaround from the week before, when several of the same stocks fell on hopes that a new deal would decrease steel and aluminum tariffs. The VanEck Steel ETF gained 1.6% on the day, while the State Street Materials Select Sector SPDR reached an intraday high. The rise didn't last: by the end of the week, the materials ETF had slipped to negative territory, while the steel ETF was about flat, though, both remain substantially up for 2026.
The volatility traces a rapid escalation. On August 19, Bloomberg reported that the US and Canada had tentatively agreed to reduce tariffs on Canadian steel and aluminum to 25% and vehicle charges to 15%. That optimism was dashed within days: on August 22, the US imposed 50% tariffs on a wide variety of Canadian exports, and Canadian Prime Minister Mark Carney responded by declaring Canada officially "at war" with the United States, saying "You're at war when you're attacked, and we got attacked."
On August 25, Ottawa announced counter-tariffs of C$27.6 billion on American goods, which took effect on September 8 at rates ranging from 15% to 50%. The dispute has continued to escalate since then, with Washington announcing additional restrictions and tariffs on Canadian goods in September, reinforcing the view that a quick resolution remains unlikely.
Atsi Sheth, Moody's chief credit officer, put it bluntly: "Expect much more of this uncertainty for some time to come." Investors initially welcomed tariffs as good news for US steelmakers facing less Canadian competition, but the back-and-forth negotiations, as well as Canada's reaction, have made predicting a steady outcome difficult.
The more intriguing story is how differently the aforementioned companies are positioned. Nucor Corporation (NYSE:NUE) relies primarily on scrap-based electric arc furnace steelmaking, while Cleveland-Cliffs Inc. (NYSE:CLF) operates a vertically integrated model with internally sourced iron ore, scrap and other raw materials. Both have meaningful domestic raw-material exposure, although their production models differ substantially. Nucor Corporation (NYSE:NUE) is up more than 50% year-to-date, while Cleveland-Cliffs Inc. (NYSE:CLF), despite similar structural insulation, remains negative for 2026, which **** ysts attribute to balance sheet stress rather than tariffs.
#august #nucor #corporation #cleveland
The volatility traces a rapid escalation. On August 19, Bloomberg reported that the US and Canada had tentatively agreed to reduce tariffs on Canadian steel and aluminum to 25% and vehicle charges to 15%. That optimism was dashed within days: on August 22, the US imposed 50% tariffs on a wide variety of Canadian exports, and Canadian Prime Minister Mark Carney responded by declaring Canada officially "at war" with the United States, saying "You're at war when you're attacked, and we got attacked."
On August 25, Ottawa announced counter-tariffs of C$27.6 billion on American goods, which took effect on September 8 at rates ranging from 15% to 50%. The dispute has continued to escalate since then, with Washington announcing additional restrictions and tariffs on Canadian goods in September, reinforcing the view that a quick resolution remains unlikely.
Atsi Sheth, Moody's chief credit officer, put it bluntly: "Expect much more of this uncertainty for some time to come." Investors initially welcomed tariffs as good news for US steelmakers facing less Canadian competition, but the back-and-forth negotiations, as well as Canada's reaction, have made predicting a steady outcome difficult.
The more intriguing story is how differently the aforementioned companies are positioned. Nucor Corporation (NYSE:NUE) relies primarily on scrap-based electric arc furnace steelmaking, while Cleveland-Cliffs Inc. (NYSE:CLF) operates a vertically integrated model with internally sourced iron ore, scrap and other raw materials. Both have meaningful domestic raw-material exposure, although their production models differ substantially. Nucor Corporation (NYSE:NUE) is up more than 50% year-to-date, while Cleveland-Cliffs Inc. (NYSE:CLF), despite similar structural insulation, remains negative for 2026, which **** ysts attribute to balance sheet stress rather than tariffs.
#august #nucor #corporation #cleveland
16 days ago
Some offers on this page are from advertisers who pay us, which may affect which products we write about, but not our recommendations. See our Advertiser Disclosure.
The Federal Open Market Committee (FOMC) is meeting this week. During these meetings, the committee ****** ses the health of the economy and potentially adjusts the federal funds rate. Read on to learn more about the timeline for this meeting, what it involves, and expected outcomes.
The latest FOMC meeting takes place on September 15-16, 2026. This is its sixth scheduled meeting of the year.
Once the meeting concludes, the FOMC will release its policy decisions on Wednesday at 2 p.m. Eastern time. Then the Fed chairman will hold a news conference at 2:30 p.m.
The live news conferences, held by the Federal Reserve chairman, are livestreamed and recorded. Additionally, the minutes of regularly scheduled meetings are released three weeks after the date of the policy decision.
#federal #chairman
The Federal Open Market Committee (FOMC) is meeting this week. During these meetings, the committee ****** ses the health of the economy and potentially adjusts the federal funds rate. Read on to learn more about the timeline for this meeting, what it involves, and expected outcomes.
The latest FOMC meeting takes place on September 15-16, 2026. This is its sixth scheduled meeting of the year.
Once the meeting concludes, the FOMC will release its policy decisions on Wednesday at 2 p.m. Eastern time. Then the Fed chairman will hold a news conference at 2:30 p.m.
The live news conferences, held by the Federal Reserve chairman, are livestreamed and recorded. Additionally, the minutes of regularly scheduled meetings are released three weeks after the date of the policy decision.
#federal #chairman
17 days ago
Broyhill ***** et Management, a Charlotte-based firm, issued its second-quarter 2026 investor letter, which is available for download here. The Broyhill Equity Composite gained 8.8% in Q2, trailing the MSCI All Country World Index's 15.1% and the MSCI ACWI Value Index's 10.8%. For the first half, the Composite returned 2.3%, versus 11.5% for the Index. The letter highlights that a significant portion of the shortfall occurred in April due to market dynamics and geopolitical events, with tech, particularly semiconductors, driving recent gains. Broyhill notes its lack of direct semiconductor exposure but acknowledges potential interest in the sector if opportunities arise, maintaining its investment philosophy focused on capital protection in fragile market conditions. Also, check the fund's top five holdings to see its best picks in 2026.
In its second-quarter 2026 investor letter, Broyhill ***** et Management highlighted ServiceNow, Inc. (NYSE:NOW). ServiceNow, Inc. (NYSE:NOW) is a cloud-based software company that provides a platform for automating and managing digital workflows. On September 14, 2026, ServiceNow, Inc. (NYSE:NOW) closed at $142.35 per share. Over the past month, ServiceNow, Inc. (NYSE:NOW) returned 18.32%, but its shares are down 24.15% over the past year. ServiceNow, Inc. (NYSE:NOW) has a market capitalization of $147.19 billion, and its stock has traded within a 52-week range of $81.24 to $194.73.
Broyhill ***** et Management stated the following regarding ServiceNow, Inc. (NYSE:NOW) in its Q2 2026 investor letter:
"ServiceNow, Inc. (NYSE:NOW), added in May, fell 21%. The general argument against software fits it poorly. The Now ***** ist annual contract value target was raised by 50% to $1.5 billion, customers spending more than $1 million on it grew 130% year over year, more than half of new business is now priced on consumption rather than seats, and the gross renewal rate is 97%. That is not the profile of an obvious AI victim. While we exited other related exposure where we could not frame the range of outcomes with enough confidence to hold the position (HubSpot and Intuit), we added to ServiceNow."
ServiceNow, Inc. (NYSE:NOW) is not on our list of the 40 Most Popular Stocks Among Hedge Funds. According to our database, 115 hedge fund portfolios held ServiceNow, Inc. (NYSE:NOW) at the end of the second quarter, compared to 108 in the previous quarter. While we acknowledge the potential of ServiceNow, Inc. (NYSE:NOW) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
#servicenow #management #quarter #investor
In its second-quarter 2026 investor letter, Broyhill ***** et Management highlighted ServiceNow, Inc. (NYSE:NOW). ServiceNow, Inc. (NYSE:NOW) is a cloud-based software company that provides a platform for automating and managing digital workflows. On September 14, 2026, ServiceNow, Inc. (NYSE:NOW) closed at $142.35 per share. Over the past month, ServiceNow, Inc. (NYSE:NOW) returned 18.32%, but its shares are down 24.15% over the past year. ServiceNow, Inc. (NYSE:NOW) has a market capitalization of $147.19 billion, and its stock has traded within a 52-week range of $81.24 to $194.73.
Broyhill ***** et Management stated the following regarding ServiceNow, Inc. (NYSE:NOW) in its Q2 2026 investor letter:
"ServiceNow, Inc. (NYSE:NOW), added in May, fell 21%. The general argument against software fits it poorly. The Now ***** ist annual contract value target was raised by 50% to $1.5 billion, customers spending more than $1 million on it grew 130% year over year, more than half of new business is now priced on consumption rather than seats, and the gross renewal rate is 97%. That is not the profile of an obvious AI victim. While we exited other related exposure where we could not frame the range of outcomes with enough confidence to hold the position (HubSpot and Intuit), we added to ServiceNow."
ServiceNow, Inc. (NYSE:NOW) is not on our list of the 40 Most Popular Stocks Among Hedge Funds. According to our database, 115 hedge fund portfolios held ServiceNow, Inc. (NYSE:NOW) at the end of the second quarter, compared to 108 in the previous quarter. While we acknowledge the potential of ServiceNow, Inc. (NYSE:NOW) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
#servicenow #management #quarter #investor
17 days ago
Cipher Digital (NASDAQ: CIFR) stock is roaring higher on Wednesday. The company's share price was up 13.9% as of 10:35 a.m. ET. At the same point in the daily session, the S&P 500 and the Nasdaq Composite were up 0.2% and 0.6%, respectively.
After recent sell-offs driven by concerns about the potential for increased regulation in the artificial intelligence (AI) industry, stocks in the category are seeing some rebound trading in today's session. In addition to that bullish catalyst, Cipher Digital stock is getting a big boost from news connected to its Texas data center projects.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
The potential for AI to create dangerous outcomes has been a center-stage news item and point of political discussion recently, and increased focus on the topic has powered some valuation pullbacks for artificial intelligence companies. Calls for increased regulation of the AI industry have caused concerns among investors that growth in the category could be impeded, but stocks in the ******* e are broadly seeing some rebound momentum in today's trading.
Before the market opened this morning, the Electric Reliability Council of Texas (ERCOT) published an update through its Batch Zero evaluation framework indicating grid capacity of up to 3.2 gigawatts for Cipher's data centers in the state. The update bodes well for the scaling of the company's AI compute business, and investors are bidding up the stock today in response.
#NVIDIA #Stock #increased #flashing
After recent sell-offs driven by concerns about the potential for increased regulation in the artificial intelligence (AI) industry, stocks in the category are seeing some rebound trading in today's session. In addition to that bullish catalyst, Cipher Digital stock is getting a big boost from news connected to its Texas data center projects.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
The potential for AI to create dangerous outcomes has been a center-stage news item and point of political discussion recently, and increased focus on the topic has powered some valuation pullbacks for artificial intelligence companies. Calls for increased regulation of the AI industry have caused concerns among investors that growth in the category could be impeded, but stocks in the ******* e are broadly seeing some rebound momentum in today's trading.
Before the market opened this morning, the Electric Reliability Council of Texas (ERCOT) published an update through its Batch Zero evaluation framework indicating grid capacity of up to 3.2 gigawatts for Cipher's data centers in the state. The update bodes well for the scaling of the company's AI compute business, and investors are bidding up the stock today in response.
#NVIDIA #Stock #increased #flashing
17 days ago
An ******* ysis of recent filings from American politicians shows that Accenture (NYSE: ACN) and Boston Scientific (NYSE: BSX) saw an uptick in purchases from notable politicians. Rep. Gilbert Ray Cisneros, Jr. (D-CA) bought Boston Scientific shares, according to a filing earlier this month. The trade was made on August 18, 2026. Rep. Ro Khanna (D-CA) also bought the stock twice, on August 3 and August 10, 2026, according to a filing filed on September 4, 2026. Neither politician sold Boston Scientific shares in the same period. Cisneros and Khanna were also the two buyers of Accenture shares in July and August.
This is based on data from Quiver Quantitative, a platform that tracks congressional stock trades from politicians.
Let's focus on BSX in this article.
BSX is down about 50% so far this year amid a cyberattack that disrupted manufacturing, order processing and shipments, forcing the company to withdraw its previous third-quarter and full-year outlook. Bulls say the market has priced in too severe an outcome. By Sept. 8, the company said its major distribution centers were shipping at or above normal levels, sterilization facilities were operating, and manufacturing had restarted at most plants. Bulls believe much of the disrupted revenue could be delayed rather than permanently lost as hospitals wait for products, reschedule procedures and the company works through its backlog.
Bulls also point to a business that was still growing. Second-quarter revenue rose 7.5% year over year and organic growth was 7%. Several core franchises delivered double-digit organic growth, including Interventional Cardiology and Vascular Therapies, Interventional Oncology and Embolization, and Neuromodulation.
#accenture
This is based on data from Quiver Quantitative, a platform that tracks congressional stock trades from politicians.
Let's focus on BSX in this article.
BSX is down about 50% so far this year amid a cyberattack that disrupted manufacturing, order processing and shipments, forcing the company to withdraw its previous third-quarter and full-year outlook. Bulls say the market has priced in too severe an outcome. By Sept. 8, the company said its major distribution centers were shipping at or above normal levels, sterilization facilities were operating, and manufacturing had restarted at most plants. Bulls believe much of the disrupted revenue could be delayed rather than permanently lost as hospitals wait for products, reschedule procedures and the company works through its backlog.
Bulls also point to a business that was still growing. Second-quarter revenue rose 7.5% year over year and organic growth was 7%. Several core franchises delivered double-digit organic growth, including Interventional Cardiology and Vascular Therapies, Interventional Oncology and Embolization, and Neuromodulation.
#accenture
17 days ago
The Federal Reserve is expected to raise its benchmark interest rate by a quarter percentage point at its meeting Wednesday, which would mark the first increase since July 2023, according to CNBC. CME Group's FedWatch tool showed traders placing odds above 90% on a hike, an outcome that would set the federal funds rate target range at 3.75%–4%.
That would follow a period in which the FOMC reduced rates on six separate occasions totaling 175 basis points from July 2023 through early 2026, according to CNBC. Since then, a string of discouraging inflation readings, a firm labor market, and crude oil prices rising back above $100 a barrel — driven by the conflict involving Iran — have shifted the calculus toward tightening.
Fed Chair Kevin Warsh's remarks at the Fed's annual Jackson Hole symposium helped accelerate that shift, according to CNBC. As recently as a month ago, futures markets put the probability of a hike at only 36%.
The path to Wednesday's expected decision reflects a committee that had been moving in a hawkish direction for months. At the June meeting — Fed Chair Kevin Warsh's first — the committee voted 12–0 to hold rates steady, but the Fed released projections showing nine of 18 officials favored at least one rate hike before year-end. Consumer prices had risen 4.2% year-over-year in May, a three-year high. Warsh said at the time that the Fed's commitment to bringing down inflation was "strong, unanimous, and unambiguous."
Minutes from the July meeting, when the committee held rates steady on a fractured 9–3 vote, showed hawkish sentiment extended beyond the three dissenting regional bank presidents who had pushed for an immediate increase. The minutes indicated that "some policy firming would likely be warranted" if inflation remained persistent, driven by factors including AI-fueled demand, Middle East energy disruptions, or tariff pass-through.
#cnbc #hike #rates #inflation
That would follow a period in which the FOMC reduced rates on six separate occasions totaling 175 basis points from July 2023 through early 2026, according to CNBC. Since then, a string of discouraging inflation readings, a firm labor market, and crude oil prices rising back above $100 a barrel — driven by the conflict involving Iran — have shifted the calculus toward tightening.
Fed Chair Kevin Warsh's remarks at the Fed's annual Jackson Hole symposium helped accelerate that shift, according to CNBC. As recently as a month ago, futures markets put the probability of a hike at only 36%.
The path to Wednesday's expected decision reflects a committee that had been moving in a hawkish direction for months. At the June meeting — Fed Chair Kevin Warsh's first — the committee voted 12–0 to hold rates steady, but the Fed released projections showing nine of 18 officials favored at least one rate hike before year-end. Consumer prices had risen 4.2% year-over-year in May, a three-year high. Warsh said at the time that the Fed's commitment to bringing down inflation was "strong, unanimous, and unambiguous."
Minutes from the July meeting, when the committee held rates steady on a fractured 9–3 vote, showed hawkish sentiment extended beyond the three dissenting regional bank presidents who had pushed for an immediate increase. The minutes indicated that "some policy firming would likely be warranted" if inflation remained persistent, driven by factors including AI-fueled demand, Middle East energy disruptions, or tariff pass-through.
#cnbc #hike #rates #inflation
17 days ago
Oracle Chief Financial Officer Hilary Maxson told employees on Tuesday that the company's latest round of layoffs should not be understood as a directive to do more with fewer resources, according to Business Insider, which reviewed a recording of the remarks.
"I don't mean doing more with less, which is a phrase that I really, really don't like," Maxson said. "It means simplifying processes that don't help customers and making clear choices on where we're going to use our resources where they have the greatest impact."
The comments came during Maxson's first companywide meeting since joining Oracle, held one day after the company began a new round of job cuts. According to Business Insider, the layoffs went unmentioned by Maxson and the other executives who spoke during the roughly hour-long town hall. Instead, executives focused on growth, customer demand, and artificial intelligence.
Co-CEO Mike Sicilia used the meeting to offer employees a mantra for the quarter. "I'd ask you to keep asking a very simple question: How does the work that I'm doing help deliver a better outcome for a customer?" Sicilia said. "There's a lot of change around this, a lot going on in the world, and in moments like this, how we work together and how we show up for our customers and for each other matters most."
The latest cuts follow a significant reduction in Oracle's workforce over the past year. According to a regulatory filing, Oracle shed approximately 21,000 positions — representing about 13% of its workforce — across the fiscal year that closed on May 31, 2026.
#business #round
"I don't mean doing more with less, which is a phrase that I really, really don't like," Maxson said. "It means simplifying processes that don't help customers and making clear choices on where we're going to use our resources where they have the greatest impact."
The comments came during Maxson's first companywide meeting since joining Oracle, held one day after the company began a new round of job cuts. According to Business Insider, the layoffs went unmentioned by Maxson and the other executives who spoke during the roughly hour-long town hall. Instead, executives focused on growth, customer demand, and artificial intelligence.
Co-CEO Mike Sicilia used the meeting to offer employees a mantra for the quarter. "I'd ask you to keep asking a very simple question: How does the work that I'm doing help deliver a better outcome for a customer?" Sicilia said. "There's a lot of change around this, a lot going on in the world, and in moments like this, how we work together and how we show up for our customers and for each other matters most."
The latest cuts follow a significant reduction in Oracle's workforce over the past year. According to a regulatory filing, Oracle shed approximately 21,000 positions — representing about 13% of its workforce — across the fiscal year that closed on May 31, 2026.
#business #round
19 days ago
A day after a disappointing outcome at the Solheim Cup, U.S. captain Angela Stanford has a new gig.
Stanford has joined the TCU women's golf team as an ***** istant coach.
TCU's website said: "The greatest player in TCU women's golf history is back in purple and white."
Stanford, who is from nearby Saginaw, Texas, about 15 miles away from Ft. Worth, was a four-time All-American for the Horned Frogs from 1996-2000, the only four-time All-American in program history. Stanford holds the school record for wins with 10.
"We are absolutely thrilled to welcome Angela Stanford back home to TCU as our third coach," said TCU head coach Ravaioli-Larkin. "As one of the most decorated and respected figures in golf history, her transition from a legendary professional career to our coaching staff is a monumental moment for our program. Angela's elite competitive experience as a major champion, combined with her leadership as a U.S. Solheim Cup captain, will provide our student-athletes with unparalleled mentorship. She embodies what it means to be a Horned Frog, and her passion for TCU will undoubtedly elevate our team to new heights."
#history #solheim
Stanford has joined the TCU women's golf team as an ***** istant coach.
TCU's website said: "The greatest player in TCU women's golf history is back in purple and white."
Stanford, who is from nearby Saginaw, Texas, about 15 miles away from Ft. Worth, was a four-time All-American for the Horned Frogs from 1996-2000, the only four-time All-American in program history. Stanford holds the school record for wins with 10.
"We are absolutely thrilled to welcome Angela Stanford back home to TCU as our third coach," said TCU head coach Ravaioli-Larkin. "As one of the most decorated and respected figures in golf history, her transition from a legendary professional career to our coaching staff is a monumental moment for our program. Angela's elite competitive experience as a major champion, combined with her leadership as a U.S. Solheim Cup captain, will provide our student-athletes with unparalleled mentorship. She embodies what it means to be a Horned Frog, and her passion for TCU will undoubtedly elevate our team to new heights."
#history #solheim
19 days ago
Ole Miss news: Pete Golding's NSFW comment says it all about Kiffin return appeared first on ClutchPoints. Add ClutchPoints as a Preferred Source by clicking here.
Perhaps the biggest game of the Week 3 slate in college football is Lane Kiffin and LSU football heading to play against Pete Golding and Ole Miss. The villainous nature of Lane Kiffin is well documented. After leaving the Rebels last season before the playoffs, he allegedly left his dog behind while also trying to bring Ole Miss players to LSU. After all that, he tried to bring in players who were on NFL rosters in the offseason, and LSU ended up being sued. Now, Kiffin is returning to Ole Miss for a Week 3 game, looking for revenge.
As the game between Ole Miss and LSU approaches, Rebels head coach Pete Golding is summing up what it is like to welcome Kiffin back to town, per Trey Wallace.
"To me, it's like high school homecoming for these dudes. Like, if you focus on the wrong s**t, that homecoming dance ain't very fun after you get your **** beat on a Friday night. So we got to make sure we're doing everything right throughout the week to get the outcome that we want," Golding said.
Watch sports LIVE with fuboTV (free trial)
#rebels
Perhaps the biggest game of the Week 3 slate in college football is Lane Kiffin and LSU football heading to play against Pete Golding and Ole Miss. The villainous nature of Lane Kiffin is well documented. After leaving the Rebels last season before the playoffs, he allegedly left his dog behind while also trying to bring Ole Miss players to LSU. After all that, he tried to bring in players who were on NFL rosters in the offseason, and LSU ended up being sued. Now, Kiffin is returning to Ole Miss for a Week 3 game, looking for revenge.
As the game between Ole Miss and LSU approaches, Rebels head coach Pete Golding is summing up what it is like to welcome Kiffin back to town, per Trey Wallace.
"To me, it's like high school homecoming for these dudes. Like, if you focus on the wrong s**t, that homecoming dance ain't very fun after you get your **** beat on a Friday night. So we got to make sure we're doing everything right throughout the week to get the outcome that we want," Golding said.
Watch sports LIVE with fuboTV (free trial)
#rebels
19 days ago
Amgen Inc. (NASDAQ:AMGN) shed roughly $12 billion in market value after hours on September 4, 2026. The stock declined by about 5% to $415. The reason, as strange as it sounds, is a drug it does not own. Novartis announced that pelacarsen, an Lp(a)-lowering therapy, missed its Phase 3 cardiovascular-outcomes trial, Lp(a)HORIZON. And since Amgen's late-stage ******* et olpasiran relies on the same biological premise, investors immediately marked down Amgen on the negative read-through.
The result strikes at a premise rather than at a product. Pelacarsenhad lowered Lp(a) by roughly 80% in earlier studies. In Lp(a)HORIZON, Novartis said pelacarsen substantially lowered Lp(a), but it still failed to reduce the composite of cardiovascular death, heart attack, stroke, and urgent revascularization. It still could not reduce the composite of cardiovascular death, heart attack, stroke, and urgent revascularization. And now the entire hypothesis that lowering Lp(a), a genetic cardiovascular risk factor, actually cuts events, is being directly challenged. Olpasiran is built on the same hypothesis, leading to the repricing of odds as soon as pelacarsen's data were out.
Amgen's olpasiran, an siRNA, lowered Lp(a) by more than 95% at certain doses in Phase 2, compared with reductions of roughly 80% for pelacarsen in earlier studies. The bull case is that this deeper reduction could help olpasiran deliver better cardiovascular outcomes.. The bull case is that this 15% will help Amgen to make a deeper cut and deliver results. While biologically possible, the Lp(a)HORIZON trial provided no evidence that a clinical threshold exists above an 80% reduction. The topline Phase 3 announcement did not establish that deeper Lp(a) lowering would have produced a cardiovascular benefit. It is therefore appropriate to say that the miss lowered olpasiran's probability of success rather than pretending it is irrelevant. Eli Lilly's lepodisiran is running the same deep-reduction experiment, so the hypothesis will be tested with or without Amgen.
Amgen is not an Lp(a) pure-play. MariTide in obesity, Repatha in cholesterol, and Tezspire in asthma drive more value for the company, and this diversification creates a cushion for the stock, although the selloff ultimately became much larger than the initial 5% after-hours reaction. Positioning has stayed calm since the beginning of 2026. Insider Monkey data shows 66 hedge funds held AMGN in the second quarter of 2026, up slightly from 65 in the first. Short interest, on the other hand, sits at just 2.4% of float, reflecting minimal bets against the stock in the market.
#horizon #pelacarsen
The result strikes at a premise rather than at a product. Pelacarsenhad lowered Lp(a) by roughly 80% in earlier studies. In Lp(a)HORIZON, Novartis said pelacarsen substantially lowered Lp(a), but it still failed to reduce the composite of cardiovascular death, heart attack, stroke, and urgent revascularization. It still could not reduce the composite of cardiovascular death, heart attack, stroke, and urgent revascularization. And now the entire hypothesis that lowering Lp(a), a genetic cardiovascular risk factor, actually cuts events, is being directly challenged. Olpasiran is built on the same hypothesis, leading to the repricing of odds as soon as pelacarsen's data were out.
Amgen's olpasiran, an siRNA, lowered Lp(a) by more than 95% at certain doses in Phase 2, compared with reductions of roughly 80% for pelacarsen in earlier studies. The bull case is that this deeper reduction could help olpasiran deliver better cardiovascular outcomes.. The bull case is that this 15% will help Amgen to make a deeper cut and deliver results. While biologically possible, the Lp(a)HORIZON trial provided no evidence that a clinical threshold exists above an 80% reduction. The topline Phase 3 announcement did not establish that deeper Lp(a) lowering would have produced a cardiovascular benefit. It is therefore appropriate to say that the miss lowered olpasiran's probability of success rather than pretending it is irrelevant. Eli Lilly's lepodisiran is running the same deep-reduction experiment, so the hypothesis will be tested with or without Amgen.
Amgen is not an Lp(a) pure-play. MariTide in obesity, Repatha in cholesterol, and Tezspire in asthma drive more value for the company, and this diversification creates a cushion for the stock, although the selloff ultimately became much larger than the initial 5% after-hours reaction. Positioning has stayed calm since the beginning of 2026. Insider Monkey data shows 66 hedge funds held AMGN in the second quarter of 2026, up slightly from 65 in the first. Short interest, on the other hand, sits at just 2.4% of float, reflecting minimal bets against the stock in the market.
#horizon #pelacarsen
19 days ago
New customers who use Fanatics Sportsbook promo code YAHOO350 when they place a first bet of at least $20 can receive up to $350 in FanCash, valid across a wide array of Fanatics experiences. This holds whether the original bet wins or loses, and, among other things, you can wager on the first Monday Night Football game of the NFL season.
Eligibility for the promotional FanCash is not dependent on the outcome of the bet, but the wager must have odds of -500 or longer, so be sure to check the current odds and don't pick too big of a favorite for the initial wager.
CLICK HERE: Snag $350 in FanCash after a $20 bet with Fanatics Sportsbook promo code YAHOO350!
New customers in AZ, CO, CT, DC, IA, IL, IN, KS, KY, LA, MA, MD, MI, MO, NC, NJ, OH, PA, TN, VA, VT, WV, WY. Must toggle on this promotion in your bet slip and wager $20+ cash on any market (min. odds -500) within 7 days of account opening to receive $50 in FanCash each day for your first 7 days. Must opt in each day to claim FanCash. FanCash issued in connection with this Promotion expire 24 hours from issuance. Terms apply-see Fanatics Sportsbook app.
This page contains affiliate links. A commission or other compensation may be earned when you click through.
#fancash #must
Eligibility for the promotional FanCash is not dependent on the outcome of the bet, but the wager must have odds of -500 or longer, so be sure to check the current odds and don't pick too big of a favorite for the initial wager.
CLICK HERE: Snag $350 in FanCash after a $20 bet with Fanatics Sportsbook promo code YAHOO350!
New customers in AZ, CO, CT, DC, IA, IL, IN, KS, KY, LA, MA, MD, MI, MO, NC, NJ, OH, PA, TN, VA, VT, WV, WY. Must toggle on this promotion in your bet slip and wager $20+ cash on any market (min. odds -500) within 7 days of account opening to receive $50 in FanCash each day for your first 7 days. Must opt in each day to claim FanCash. FanCash issued in connection with this Promotion expire 24 hours from issuance. Terms apply-see Fanatics Sportsbook app.
This page contains affiliate links. A commission or other compensation may be earned when you click through.
#fancash #must
19 days ago
After watching the tape and re-evaluating the outlook of Sunday's 36-31 loss to the Buffalo Bills, here's everything Houston Texans head coach DeMeco Ryans had to say on Monday about the outcome, what went wrong and where the team can improve entering Week 2.
Question: On how to eliminate explosive plays as a defense
DeMeco Ryans: "To eliminate explosive plays, it starts by simply guys doing their job, being where they're supposed to be. Whether it's coverage, leverage, or being outside, being inside, being on top, where we're supposed to be, how we're rushing, our rush plan, also all that ties in together. We gave up 11 or 12 explosive plays and when you give up that many plays, you're going to give up points. We have to do a much better job of just being where we're supposed to be, finishing how we're supposed to finish."
Q: On trusting the process
Ryans: "You definitely have to trust the process when it just comes to doing what we're supposed to do. The Bills, they made some plays and made some good catches, but when we're not where we're supposed to be, we're going to make it look even better. It always starts with us about just doing the things that you're supposed to do to help you win the game."
#we 're
Question: On how to eliminate explosive plays as a defense
DeMeco Ryans: "To eliminate explosive plays, it starts by simply guys doing their job, being where they're supposed to be. Whether it's coverage, leverage, or being outside, being inside, being on top, where we're supposed to be, how we're rushing, our rush plan, also all that ties in together. We gave up 11 or 12 explosive plays and when you give up that many plays, you're going to give up points. We have to do a much better job of just being where we're supposed to be, finishing how we're supposed to finish."
Q: On trusting the process
Ryans: "You definitely have to trust the process when it just comes to doing what we're supposed to do. The Bills, they made some plays and made some good catches, but when we're not where we're supposed to be, we're going to make it look even better. It always starts with us about just doing the things that you're supposed to do to help you win the game."
#we 're
19 days ago
TAMPA, Fla. (AP) — The Tampa Bay Buccaneers saw the best and worst of Baker Mayfield in their first season-opening loss since 2020.
Tom Brady led them to a Super Bowl ***** le that season so 0-1 isn't an insurmountable deficit.
Plus, every team in the NFC South lost on Sunday.
Mayfield lost three fumbles that led to 17 points, including one that was returned for a score in Tampa Bay's 33-27 loss to Cincinnati. He also held the ball took long at times, taking four sacks. But Mayfield had an efficient game when he wasn't giving the ball away. He completed 23 of 28 passes for 216 yards and ran for 30 yards, including a touchdown.
If Mayfield protected the ball, the outcome would've been different.
#yards #buccaneers
Tom Brady led them to a Super Bowl ***** le that season so 0-1 isn't an insurmountable deficit.
Plus, every team in the NFC South lost on Sunday.
Mayfield lost three fumbles that led to 17 points, including one that was returned for a score in Tampa Bay's 33-27 loss to Cincinnati. He also held the ball took long at times, taking four sacks. But Mayfield had an efficient game when he wasn't giving the ball away. He completed 23 of 28 passes for 216 yards and ran for 30 yards, including a touchdown.
If Mayfield protected the ball, the outcome would've been different.
#yards #buccaneers
19 days ago
Gold and silver investors have had to contend with some sharp price moves so far in 2026. Gold, for example, surpassed $5,500 per ounce early this year, but has since retreated significantly from that record high, with the price of gold sitting closer to $4,275 per ounce as of mid-September. Silver, on the other hand, has also experienced sizable price swings as investors have responded to shifting expectations for inflation, interest rates and the economy.
And those price movements could become even more **** ounced in the days ahead. The Federal Reserve meets September 15 and 16, and persistent inflation has increased the possibility of another rate hike. That prospect matters for precious metals investors because changes in interest rates can quickly alter where investors put their money and how much they're willing to pay for **** ets such as gold and silver.
Still, the outcome isn't as simple as higher rates automatically leading to lower precious metals prices. Gold and silver are being pulled by several competing forces right now, and the Fed's decision is only one of them. So, if the central bank does raise rates this week, what could it actually mean for gold and silver prices — both immediately and in the months that follow? That's what we'll examine below.
Find out how you can use gold and silver to protect your portfolio today.
If the Fed raises rates at its September meeting, gold and silver prices could face some short-term pressure, as higher interest rates tend to make other interest-bearing options, such as bonds and savings products, more attractive. Gold and silver **** ets don't pay interest, though, so some investors may be less willing to hold them when they can earn higher returns elsewhere.
#Gold #silver #rates #ounce
And those price movements could become even more **** ounced in the days ahead. The Federal Reserve meets September 15 and 16, and persistent inflation has increased the possibility of another rate hike. That prospect matters for precious metals investors because changes in interest rates can quickly alter where investors put their money and how much they're willing to pay for **** ets such as gold and silver.
Still, the outcome isn't as simple as higher rates automatically leading to lower precious metals prices. Gold and silver are being pulled by several competing forces right now, and the Fed's decision is only one of them. So, if the central bank does raise rates this week, what could it actually mean for gold and silver prices — both immediately and in the months that follow? That's what we'll examine below.
Find out how you can use gold and silver to protect your portfolio today.
If the Fed raises rates at its September meeting, gold and silver prices could face some short-term pressure, as higher interest rates tend to make other interest-bearing options, such as bonds and savings products, more attractive. Gold and silver **** ets don't pay interest, though, so some investors may be less willing to hold them when they can earn higher returns elsewhere.
#Gold #silver #rates #ounce
